מטוג'קט 50 מ"ג / מ"ל

Χώρα: Ισραήλ

Γλώσσα: Εβραϊκά

Πηγή: Ministry of Health

Δραστική ουσία:

METHOTREXATE 50 MG/ML

Διαθέσιμο από:

TZAMAL BIO-PHARMA LTD

Φαρμακολογική κατηγορία (ATC):

L01BA01

Φαρμακοτεχνική μορφή:

SOLUTION FOR INJECTION

Οδός χορήγησης:

S.C, I.M, I.V

Κατασκευάζεται από:

MEDAC GESELLSCHAFT FUER KLIN.SPEZIAL.mbh

Θεραπευτική ομάδα:

METHOTREXATE

Θεραπευτικές ενδείξεις:

Psoriasis:because of the high risk attending its use, Methotrexate is indicated only in the symptomatic control of severe recalcitrant, disabling psoriasis which is not adequately responsive to other forms of therapy, and only when the diagnosis has been established, as by biopsy and/or after dermatological consultation. Rheumatoid Arthritis: Methotrexate can be used in the treatment of selected adults with severe rheumatoid arthritis, only when the diagnosis has been well estabished according to rheumatological standards, with inadequate response to other forms of antirheumatic therapy, including full dose NSAIDs and usually a trial of at least one or more disease-modifying antirheumatic drugs.Juvenile Idiopathic Arthritis:Treatment of Polyarthritic forms of severe, active juvenile idiopathic arthritis when the response to non-steroidal anti-inflammatory drugs (NSAIDs) has been inadequate

Ημερομηνία της άδειας:

2011-02-01